Search Results

0 results for 'Kite Pharma'

You can use to get even better search results
January 12, 2024 | New York Law Journal

Pharmaceutical Legal and Regulatory Trends To Watch in 2024

This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.
8 minute read
August 15, 2023 | The Recorder

Cancer Treatment Developer Hires Biotech Veteran for GC Role

Allogene's newly hired general counsel Earl Douglas said he was drawn to the South San Francisco-based company's "deep commitment to scientific innovation, experience and leadership."
3 minute read
August 15, 2023 | Corporate Counsel

Cancer Treatment Developer Hires Biotech Veteran for GC Role

Allogene's newly hired general counsel Earl Douglas said he was drawn to the company's "deep commitment to scientific innovation, experience and leadership."
3 minute read
November 15, 2022 | The Recorder

4-Partner IP Litigation Team Decamps Milbank for Orrick in Southern California

Orrick has filled a gap in its IP litigation practice in the life sciences sector with a team, originally formed at Irell & Manella, that represents Genentech and Gilead Sciences.
4 minute read
November 10, 2022 | Law.com

Skilled in the Art With Scott Graham: Connolly Pokes and Prods at PAEs at First Hearing Into Ownership Structures + Supreme Court Bull Is Heading for Pharma Patent China Shop

Shaw Keller partner Andrew Russell described the hearing into Lamplight Licensing, Nimitz Technologies and Mellaconic IP as "one of the most remarkable hearings I've seen in a patent case."
6 minute read
November 08, 2022 | Supreme Court Brief

Indian Law Blockbuster | $1.2 Billion Patent Denial | Judges, AKA Historians

The justices today hear the longest argument of this final week of the November argument session. We speak with Kathryn Fort, head of the ICWA appellate project at Michigan State University College of Law, the case.
6 minute read
November 08, 2022 | National Law Journal

Mission Impossible? All-Star Lawyers Couldn't Convince Supreme Court in High-Stakes Case

Bristol-Myers Squibb had won a $1.2 billion judgment for infringement of its patent on a cancer treatment. But the justices left in place a Federal Circuit decision that invalidated the patent for failing to meet the Patent Act's written description requirement.
3 minute read
September 28, 2022 | New York Law Journal

'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket

The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case that originated in the Southern District of New York. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.
12 minute read
September 27, 2022 | National Law Journal

'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket

The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.
12 minute read
September 03, 2021 | Litigation Daily

Litigator of the Week Runners-Up and Shout Outs!

Our first runner-up this week is Josh Rosenkranz of Orrick, Herrington & Sutcliffe who scored a huge win for Gilead Sciences affiliate Kite Pharma at the Federal Circuit last week.
6 minute read

TRENDING STORIES

    Resources

    • The Ultimate Guide to Going Paperless for Law Firms

      Brought to you by Filevine

      Download Now

    • Top 10 Compliance Concerns for Private Fund Managers

      Brought to you by Ontra

      Download Now

    • The Top 10 Terms in Private Equity NDAs

      Brought to you by Ontra

      Download Now

    • 2024 Ethics & Compliance Program Effectiveness Report for North America

      Brought to you by LRN

      Download Now